BRIEF published on 04/29/2026 at 07:05, 4 months 13 days ago Sandoz annonce une forte croissance de ses biosimilaires au premier trimestre 2026 grâce à des initiatives stratégiques. Partenariat Stratégique Orientations Pour 2026 Croissance Des Biosimilaires Performance Des Ventes Nettes Analyse Régionale
BRIEF published on 04/29/2026 at 07:05, 4 months 13 days ago Blue Cap AG Reports Successful Fiscal Year and Proposes Record Dividend Blue Cap AG Dividend Proposal Financial Forecast Fiscal Year 2025 Revenue And EBITDA
BRIEF published on 04/29/2026 at 07:05, 4 months 13 days ago Blue Cap AG annonce un exercice fiscal fructueux et propose un dividende record. Prévisions Financières Proposition De Dividende Chiffre D'affaires Et EBITDA Exercice Financier 2025 Casquette Bleue AG
BRIEF published on 04/29/2026 at 07:05, 4 months 13 days ago Siltronic AG Reports Q1 2026 Results Aligned with Expectations EBITDA Margin Siltronic AG Market Outlook Sales Decrease Q1 2026 Results
BRIEF published on 04/29/2026 at 07:05, 4 months 13 days ago Siltronic AG annonce des résultats du premier trimestre 2026 conformes aux attentes Siltronic AG Baisse Des Ventes Marge D'EBITDA Perspectives Du Marché Résultats Du T1 2026
BRIEF published on 04/29/2026 at 07:05, 4 months 13 days ago VIB Vermögen AG Reports Positive Growth in 2025 Assets Under Management Real Estate Management Institutional Business 2025 Financial Growth VIB Vermögen
BRIEF published on 04/29/2026 at 07:05, 4 months 13 days ago VIB Vermögen AG annonce une croissance positive en 2025 Actifs Sous Gestion Gestion Immobilière VIB Vermögen Croissance Financière En 2025 Entreprise Institutionnelle
BRIEF published on 04/29/2026 at 07:05, 4 months 13 days ago EvoNext Holdings SA Releases 2025 Annual Report Mergers And Acquisitions Strategic Opportunities Financial Report 2025 Liquidity And Operating Loss Arbitration Outcome
BRIEF published on 04/29/2026 at 07:05, 4 months 13 days ago EvoNext Holdings SA publie son rapport annuel 2025 Fusions Et Acquisitions Opportunités Stratégiques Rapport Financier 2025 Pertes De Liquidités Et D'exploitation Résultat De L'arbitrage
BRIEF published on 04/29/2026 at 07:05, 4 months 13 days ago FORVIA HELLA's Q1 2026 Sales Steady Amid Challenging Conditions FORVIA HELLA Sales Stability Electronics Growth Q1 2026 Lighting Challenges
Published on 09/12/2026 at 02:35, 16 hours 8 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 19 hours 43 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 20 hours 38 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 21 hours 18 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day 1 hour ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 53 minutes ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 11 hours 13 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 20 hours 28 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 20 hours 33 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 22 hours 59 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 1 day 11 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 11 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 23 hours ago Availability of the 2026 Interim Financial Report
